Trademark: 90450221
Status Date
Monday, November 20, 2023
Filing Date
Wednesday, January 6, 2021
Published for Opposition
Tuesday, August 24, 2021
Abandoned Date
Monday, November 20, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Nov 20, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 20, 2023
Abandonment - No Use Statement Filed
Apr 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 31, 2023
Sou Extension 3 Granted
Mar 31, 2023
Sou Extension 3 Filed
Mar 31, 2023
Sou Teas Extension Received
Oct 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 7, 2022
Sou Extension 2 Granted
Oct 7, 2022
Sou Extension 2 Filed
Oct 7, 2022
Sou Teas Extension Received
Apr 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2022
Sou Extension 1 Granted
Apr 4, 2022
Sou Extension 1 Filed
Apr 4, 2022
Sou Teas Extension Received
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 19, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 24, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 24, 2021
Published For Opposition
Aug 4, 2021
Notification Of Notice Of Publication E-Mailed
Jul 15, 2021
Approved For Pub - Principal Register
Jul 14, 2021
Assigned To Examiner
Apr 5, 2021
New Application Office Supplied Data Entered
Jan 9, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24